rs12623957

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_022336.4(EDAR):​c.1056C>T​(p.Cys352Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.812 in 1,613,426 control chromosomes in the GnomAD database, including 539,086 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 43294 hom., cov: 32)
Exomes 𝑓: 0.82 ( 495792 hom. )

Consequence

EDAR
NM_022336.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:13

Conservation

PhyloP100: 1.71

Publications

23 publications found
Variant links:
Genes affected
EDAR (HGNC:2895): (ectodysplasin A receptor) This gene encodes a member of the tumor necrosis factor receptor family. The encoded transmembrane protein is a receptor for the soluble ligand ectodysplasin A, and can activate the nuclear factor-kappaB, JNK, and caspase-independent cell death pathways. It is required for the development of hair, teeth, and other ectodermal derivatives. Mutations in this gene result in autosomal dominant and recessive forms of hypohidrotic ectodermal dysplasia. [provided by RefSeq, Jul 2008]
RANBP2 (HGNC:9848): (RAN binding protein 2) RAN is a small GTP-binding protein of the RAS superfamily that is associated with the nuclear membrane and is thought to control a variety of cellular functions through its interactions with other proteins. This gene encodes a very large RAN-binding protein that immunolocalizes to the nuclear pore complex. The protein is a giant scaffold and mosaic cyclophilin-related nucleoporin implicated in the Ran-GTPase cycle. The encoded protein directly interacts with the E2 enzyme UBC9 and strongly enhances SUMO1 transfer from UBC9 to the SUMO1 target SP100. These findings place sumoylation at the cytoplasmic filaments of the nuclear pore complex and suggest that, for some substrates, modification and nuclear import are linked events. This gene is partially duplicated in a gene cluster that lies in a hot spot for recombination on chromosome 2q. [provided by RefSeq, Jul 2008]
RANBP2 Gene-Disease associations (from GenCC):
  • familial acute necrotizing encephalopathy
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 2-108897198-G-A is Benign according to our data. Variant chr2-108897198-G-A is described in ClinVar as Benign. ClinVar VariationId is 155865.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.71 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.928 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EDARNM_022336.4 linkc.1056C>T p.Cys352Cys synonymous_variant Exon 12 of 12 ENST00000258443.7 NP_071731.1 Q9UNE0-1
EDARXM_006712204.2 linkc.1152C>T p.Cys384Cys synonymous_variant Exon 11 of 11 XP_006712267.1 Q9UNE0-2
RANBP2XM_047445367.1 linkc.8370+124152G>A intron_variant Intron 24 of 24 XP_047301323.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EDARENST00000258443.7 linkc.1056C>T p.Cys352Cys synonymous_variant Exon 12 of 12 1 NM_022336.4 ENSP00000258443.2 Q9UNE0-1
EDARENST00000376651.1 linkc.1152C>T p.Cys384Cys synonymous_variant Exon 11 of 11 2 ENSP00000365839.1 Q9UNE0-2
EDARENST00000409271.5 linkc.1152C>T p.Cys384Cys synonymous_variant Exon 12 of 12 2 ENSP00000386371.1 Q9UNE0-2

Frequencies

GnomAD3 genomes
AF:
0.732
AC:
111136
AN:
151894
Hom.:
43284
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.439
Gnomad AMI
AF:
0.775
Gnomad AMR
AF:
0.833
Gnomad ASJ
AF:
0.882
Gnomad EAS
AF:
0.950
Gnomad SAS
AF:
0.750
Gnomad FIN
AF:
0.892
Gnomad MID
AF:
0.785
Gnomad NFE
AF:
0.834
Gnomad OTH
AF:
0.778
GnomAD2 exomes
AF:
0.821
AC:
202321
AN:
246310
AF XY:
0.822
show subpopulations
Gnomad AFR exome
AF:
0.428
Gnomad AMR exome
AF:
0.894
Gnomad ASJ exome
AF:
0.888
Gnomad EAS exome
AF:
0.964
Gnomad FIN exome
AF:
0.880
Gnomad NFE exome
AF:
0.832
Gnomad OTH exome
AF:
0.832
GnomAD4 exome
AF:
0.821
AC:
1199428
AN:
1461414
Hom.:
495792
Cov.:
64
AF XY:
0.819
AC XY:
595477
AN XY:
726978
show subpopulations
African (AFR)
AF:
0.428
AC:
14329
AN:
33476
American (AMR)
AF:
0.885
AC:
39598
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.884
AC:
23091
AN:
26134
East Asian (EAS)
AF:
0.904
AC:
35896
AN:
39698
South Asian (SAS)
AF:
0.752
AC:
64818
AN:
86248
European-Finnish (FIN)
AF:
0.878
AC:
46567
AN:
53024
Middle Eastern (MID)
AF:
0.778
AC:
4486
AN:
5768
European-Non Finnish (NFE)
AF:
0.829
AC:
921320
AN:
1111954
Other (OTH)
AF:
0.817
AC:
49323
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
12192
24384
36576
48768
60960
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20954
41908
62862
83816
104770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.731
AC:
111174
AN:
152012
Hom.:
43294
Cov.:
32
AF XY:
0.737
AC XY:
54791
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.439
AC:
18160
AN:
41404
American (AMR)
AF:
0.833
AC:
12738
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.882
AC:
3064
AN:
3472
East Asian (EAS)
AF:
0.950
AC:
4902
AN:
5160
South Asian (SAS)
AF:
0.751
AC:
3603
AN:
4800
European-Finnish (FIN)
AF:
0.892
AC:
9449
AN:
10588
Middle Eastern (MID)
AF:
0.772
AC:
227
AN:
294
European-Non Finnish (NFE)
AF:
0.834
AC:
56683
AN:
67992
Other (OTH)
AF:
0.780
AC:
1643
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1246
2491
3737
4982
6228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
816
1632
2448
3264
4080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.790
Hom.:
84910
Bravo
AF:
0.718
Asia WGS
AF:
0.789
AC:
2743
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Nov 12, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 19, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Uncertain:1Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypohidrotic Ectodermal Dysplasia, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypohidrotic ectodermal dysplasia Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Autosomal recessive hypohidrotic ectodermal dysplasia syndrome;C3888065:Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
6.4
DANN
Benign
0.56
PhyloP100
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12623957; hg19: chr2-109513654; COSMIC: COSV51508095; API